Syra Health To Discuss First Quarter 2025 Financial Results
Syra Health (OTCQB: SYRA), a healthcare technology company, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025, before market open. The company will host a conference call at 9:00 a.m. ET on the same day to discuss the results. Investors can access the conference call via webcast through the company's investor relations website and submit questions via email. A replay of the webcast will be available in the investors section of Syra Health's website.
Syra Health (OTCQB: SYRA), un'azienda tecnologica nel settore sanitario, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 8 maggio 2025, prima dell'apertura dei mercati. La società terrà una conference call alle 9:00 a.m. ET dello stesso giorno per discutere i risultati. Gli investitori potranno partecipare alla conference call tramite webcast sul sito web delle relazioni con gli investitori dell'azienda e inviare domande via email. Una registrazione del webcast sarà disponibile nella sezione investitori del sito di Syra Health.
Syra Health (OTCQB: SYRA), una empresa de tecnología sanitaria, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el jueves 8 de mayo de 2025, antes de la apertura del mercado. La compañía organizará una llamada conferencia a las 9:00 a.m. ET del mismo día para discutir los resultados. Los inversores podrán acceder a la llamada conferencia vía webcast a través del sitio web de relaciones con inversores de la empresa y enviar preguntas por correo electrónico. Una repetición del webcast estará disponible en la sección de inversores del sitio web de Syra Health.
Syra Health(OTCQB: SYRA)� 헬스케� 기술 회사로서 2025� 1분기 재무 실적 발표� 2025� 5� 8� 목요� 시장 개장 전으� 예정했습니다. 회사� 같은 � 오전 9�(동부시간)� 실적� 논의하기 위한 컨퍼런스 콜을 개최� 예정입니�. 투자자들은 회사 투자� 관� 웹사이트� 통해 웹캐스트� 컨퍼런스 콜에 접속� � 있으� 이메일로 질문� 제출� � 있습니다. 웹캐스트 녹화본은 Syra Health 웹사이트 투자� 섹션에서 이용 가능합니다.
Syra Health (OTCQB : SYRA), une entreprise de technologie de la santé, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le jeudi 8 mai 2025, avant l'ouverture des marchés. La société tiendra une conférence téléphonique à 9h00 ET le même jour pour discuter des résultats. Les investisseurs pourront accéder à la conférence téléphonique via un webcast sur le site des relations investisseurs de l'entreprise et poser des questions par email. Un replay du webcast sera disponible dans la section investisseurs du site de Syra Health.
Syra Health (OTCQB: SYRA), ein Unternehmen im Bereich Gesundheitstechnologie, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 8. Mai 2025, vor Börsenöffnung, geplant. Das Unternehmen wird am selben Tag um 9:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können über einen Webcast auf der Investor-Relations-Website des Unternehmens an der Telefonkonferenz teilnehmen und Fragen per E-Mail einreichen. Eine Aufzeichnung des Webcasts wird im Investor-Bereich der Syra Health-Website verfügbar sein.
- None.
- None.
Conference call will be held on Thursday, May 8, at 9:00 a.m. ET
Interested parties can access the conference call via webcast, available in the investors section of the company's website at .
Investors who would like to submit a question to be addressed on the call should email [email protected].
A webcast replay will be available in the investors section of the company's website at .
About Syra Health
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit .
Contacts
For Investor Inquiries:
Corbin Woodhull
Managing Director, Global Advisory
Hayden IR
602-476-1821
[email protected]
For Media Inquiries:
Christine Drury
Director of Corporate Communications
Syra Health
463-345-5180
[email protected]
View original content to download multimedia:
SOURCE Syra Health